anage continued global political and/or economic
uncertainty and disruptions, especially in the Company's significant
geographical markets, as well as any political and/or economic uncertainty
and disruptions due to a global or regional credit crisis or terrorist and
other hostile activities; (9) the ability to successfully manage
competitive factors, including prices, promotional incentives and trade
terms for products; (10) the ability to obtain patents and respond to
technological advances attained by competitors and patents granted to
competitors; (11) the ability to successfully manage increases in the
prices of raw materials used to make the Company's products; (12) the
ability to stay close to consumers in an era of increased media
fragmentation; (13) the ability to stay on the leading edge of innovation
and maintain a positive reputation on our brands; and (14) the ability to
successfully separate the Company's coffee business. For additional
information concerning factors that could cause actual results to
materially differ from those projected herein, please refer to our most
recent 10-K, 10-Q and 8-K reports.
About Procter & Gamble
Three billion times a day, P&G brands touch the lives of people around
the world. The company has one of the strongest portfolios of trusted,
quality, leadership brands, including Pampers(R), Tide(R), Ariel(R),
Always(R), Whisper(R), Pantene(R), Mach3(R), Bounty(R), Dawn(R), Gain(R),
Pringles(R), Folgers(R), Charmin(R), Downy(R), Lenor(R), Iams(R), Crest(R),
Oral-B(R), Actonel(R), Duracell(R), Olay(R), Head & Shoulders(R), Wella(R),
Gillette(R), Braun(R) and Fusion(R). The P&G community includes
approximately 138,000 employees working in over 80 countries worldwide.
Please visit http://www.pg.com for the latest news and in-depth information
about P&G and its brands.
The Procter & Gamble Company
Exhibit 1: Non-GAAP Measures
In accordance wit
'/>"/>
SOURCE The Procter & Gamble Company Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Related medicine news :1.
Cardinal Health Reports First Quarter Results2.
uKarma Reports Progress With International Distribution Agreement for Its Xflowsion DVD Series3.
STAAR Surgical Reports 33% Third Quarter Revenue Growth4.
BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza5.
Cynosure Reports 21% Revenue Growth for the Third Quarter of 20086.
LCA-Vision Reports Third Quarter 2008 Financial Results7.
Universal Health Services, Inc. Reports 2008 Third Quarter Results8.
PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results9.
Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 200910.
WellPoint Reports Third Quarter 2008 Results11.
Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80